Veterinary compositions comprising an essential oil such as cedar oil, tea oil, cardamom oil, lavender oil, cubeb oil, eucalyptus oil, mint oil, juniper oil, cypress oil, lemongrass oil, spruce oil, pine oil, fir oil, Douglas fir oil, wormwood oil, caraway oil, cumin oil, patchouli oil, sage oil, Inula oil, tansy oil, angelica oil calamus oil, ginger oil, thyme oil, Origanum oil, rosemary oil, nutmeg oil, coriander oil, geranium oil, carrot seed oil, yarrow herb or flower oil are disclosed. The essential oil may be present in the form of a complex with an organic acid or a mixture of organic acids including valerian, isovalerian, lactic, butyric, acetic, propionic, formic, benzoic, pelargonic, salicylic, malonic, citric, phthalic, tartaric, oxalic, malic, shikintic, fumaric, almond, cinnamic or derivatives thereof, and a metal including molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, or salts or oxides thereof. The compositions may be for the treatment and/or prevention of protozoan diseases in animals. Methods of manufacturing the veterinary compositions are also disclosed.

Veterinary compositions comprising an essential oil such as cedar oil, tea oil, cardamom oil, lavender oil, cubeb oil, eucalyptus oil, mint oil, juniper oil, cypress oil, lemongrass oil, spruce oil, pine oil, fir oil, Douglas fir oil, wormwood oil, caraway oil, cumin oil, patchouli oil, sage oil, Inula oil, tansy oil, angelica oil calamus oil, ginger oil, thyme oil, Origanum oil, rosemary oil, nutmeg oil, coriander oil, geranium oil, carrot seed oil, yarrow herb or flower oil are disclosed. The essential oil may be present in the form of a complex with an organic acid or a mixture of organic acids including valerian, isovalerian, lactic, butyric, acetic, propionic, formic, benzoic, pelargonic, salicylic, malonic, citric, phthalic, tartaric, oxalic, malic, shikintic, fumaric, almond, cinnamic or derivatives thereof, and a metal including molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, or salts or oxides thereof. The compositions may be for the treatment and/or prevention of protozoan diseases in animals. Methods of manufacturing the veterinary compositions are also disclosed.

A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.

A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.

The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.

The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.

The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.

Proposed is a method for manufacturing an Angelica gigas Nakai extract with an increased decursin content, an Angelica gigas Nakai extract prepared by the method, and a cosmetic composition including the Angelica gigas Nakai extract as an active ingredient, the manufacturing method including the steps of extracting Angelica gigas Nakai with ethanol; and inoculating a strain of the genus Bacillus into the ethanol extract of Angelica gigas Nakai to induce fermentation, the strain of the genus Bacillus being selected from Bacillus amyloliquefaciens and Bacillus subtilis.

Proposed is a method for manufacturing an Angelica gigas Nakai extract with an increased decursin content, an Angelica gigas Nakai extract prepared by the method, and a cosmetic composition including the Angelica gigas Nakai extract as an active ingredient, the manufacturing method including the steps of extracting Angelica gigas Nakai with ethanol; and inoculating a strain of the genus Bacillus into the ethanol extract of Angelica gigas Nakai to induce fermentation, the strain of the genus Bacillus being selected from Bacillus amyloliquefaciens and Bacillus subtilis.

There is disclosed a clear skin supplement/medicinal component for acne comprising: an orally administered dosage comprising of between about 3000-9000 mg of the Chinese medicinal composition comprising by ratio: around 3.8-7.6% of each of Prunus persica, Carthamus tinctorius, Angelica dahurica, Gleditsia sinensis, Viola yedoensis, Paeonia suffruticosa and gardenia jasminoides; around 5.7-7.6% of each of Oldenlandia diffusa and Scutellaria baicalensis; around 3.8-5.7% of Salvia miltiorrhiza; around 2.5-5.7% of Phellodendron amurense; around 2.5-7.6% of Gentiana scabra; and around 0-7.6% of each of Taraxacum mongolicum and any one of Lonicera japonica/Rhizoma Coptidas/Sophora flavescens.